231 related articles for article (PubMed ID: 32415710)
1. Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients.
Ter Heine R; Keizer RJ; van Steeg K; Smolders EJ; van Luin M; Derijks HJ; de Jager CPC; Frenzel T; Brüggemann R
Br J Clin Pharmacol; 2020 Dec; 86(12):2497-2506. PubMed ID: 32415710
[TBL] [Abstract][Full Text] [Related]
2. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
3. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
4. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
Aubron C; Corallo CE; Nunn MO; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Oct; 45(10):1193-8. PubMed ID: 21896920
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
Kanji S; Roberts JA; Xie J; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R
Clin Pharmacokinet; 2020 Mar; 59(3):327-334. PubMed ID: 31471789
[TBL] [Abstract][Full Text] [Related]
7. Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients.
Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL
Clin Microbiol Infect; 2020 Jul; ():. PubMed ID: 32673799
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
9. External Validation of Obese/Critically Ill Vancomycin Population Pharmacokinetic Models in Critically Ill Patients Who Are Obese.
Alsultan A; Dasuqi SA; Almohaizeie A; Aljutayli A; Aljamaan F; Omran RA; Alolayan A; Hamad MA; Alotaibi H; Altamimi S; Alghanem SS
J Clin Pharmacol; 2024 Mar; 64(3):353-361. PubMed ID: 37862131
[TBL] [Abstract][Full Text] [Related]
10. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Schatz LM; Brinkmann A; Röhr A; Frey O; Greppmair S; Weinelt F; Zoller M; Scharf C; Hempel G; Liebchen U
Antimicrob Agents Chemother; 2023 May; 67(5):e0010423. PubMed ID: 37125925
[TBL] [Abstract][Full Text] [Related]
11. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
[TBL] [Abstract][Full Text] [Related]
12. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
[TBL] [Abstract][Full Text] [Related]
13. Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill.
Narayan SW; Thoma Y; Drennan PG; Yejin Kim H; Alffenaar JW; Van Hal S; Patanwala AE
Crit Care Med; 2021 Oct; 49(10):e952-e960. PubMed ID: 33938713
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
16. Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates.
Kalamees R; Soeorg H; Ilmoja M-L; Margus K; Lutsar I; Metsvaht T
Antimicrob Agents Chemother; 2024 May; 68(5):e0159123. PubMed ID: 38578080
[TBL] [Abstract][Full Text] [Related]
17. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
Greppmair S; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Marsot A; El-Haffaf I; Zoller M; Saller T; Zander J; Schatz LM; Scharf C; Briegel J; Minichmayr IK; Wicha SG; Liebchen U
Intensive Care Med; 2023 Aug; 49(8):966-976. PubMed ID: 37439872
[TBL] [Abstract][Full Text] [Related]
18. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
[TBL] [Abstract][Full Text] [Related]
19. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
20. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
